Lynn Canavan, MD
Surgical Oncology · Plano, TXNPI 1760441430
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Tactile Systems Technology Inc accounts for 85.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $8,896 and has fallen 98.9% since, to $100 in 2025.
Across 59 payments — averaging $179.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$9K
- Myriad Genetic Laboratories, Inc.$653
- Endomagnetics Ltd$255
- Bone Support Inc.$146
- Johnson & Johnson$125
- Leica Microsystems Inc.$50
- plus $274 from 10 others
What the payments were for
- Speaking & faculty fees$3,60034%
- Travel & lodging$5,23949%
- Food & beverage$1,75217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 9 | $9,089 |
| Myriad Genetic Laboratories, Inc. | 32 | $653 |
| Endomagnetics Ltd | 4 | $255 |
| Bone Support Inc. | 1 | $146 |
| Johnson & Johnson | 1 | $125 |
| Leica Microsystems Inc. | 2 | $50 |
| Dilon Technologies, Inc. | 1 | $46 |
| Hologic Inc | 1 | $33 |
| Axogen | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Stryker | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Davol Inc. | 1 | $23 |
| Elucent Medical | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXITOUCH$8,829
- ACTITOUCH$8,829
- ENTRE$8,829
- CERAMENTBONE VOID FILLER$146
- CERAMENT G$146
- myRisk$128
- Magseed$126
- Magtrace$126
- XARELTO$125
How this compares
$10,591 in reported general payments places this provider in the 80th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 436 | $4,695 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 224 | $1,487 |
| Tamoxifen Citrate | 71 | $1,424 |
| Doxycycline Monohydrate | 84 | $1,399 |
| Letrozole | 25 | $717 |
| Ondansetron Hcl | 179 | $534 |
| Cephalexin | 15 | $420 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $114 |
| Cyclobenzaprine Hcl | 12 | $113 |
| Tramadol Hcl | 16 | $49 |
| Promethazine Hcl | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Plano
- Muhammad ButtPlano$7K
- Furrukh JabbarPlano$4K
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
- Steven CurleyTyler$162K
- Suhail SharifFort Worth$137K
- Alfredo Santillan GomezSan Antonio$125K
- Kelly HuntHouston$104K
- Adam YoppDallas$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.